TY  - JOUR

T1  - 1174-OR: Continuous Glucose Monitoring in Type 2 Diabetes Managed with Basal Insulin plus SGLT2 Inhibitor and/or GLP-1 Agonist: Subgroup Analysis from the FreeDM2 Trial

JO  - Diabetes

UR  - https://doi.org/10.2337/db26-1174-or

PY  - 2026/06/06

AU  - LEELARATHNA L

AU  - MOORE PJ

AU  - SATHYAPALAN T

AU  - CHOUDHARY P

AU  - LIM JZM

AU  - NEUPANE S

AU  - IQBAL A

AU  - EVANS M

AU  - RAYMAN G

AU  - PRICE H

AU  - AJJAN R et al

ED  - 

DO  - DOI: 10.2337/db26-1174-or

PB  - American Diabetes Association

VL  - 75

IS  - Supplement_1

Y2  - 2026/08/01

ER  -